Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients FH Mourad, AV Hoffbrand, M Sheikh‐Taha, S Koussa, AI Khoriaty, ... British journal of haematology 121 (1), 187-189, 2003 | 203 | 2003 |
Comparison between deferoxamine and deferiprone (L1) in iron‐loaded thalassemia patients A Taher, M Sheikh‐Taha, S Koussa, A Inati, R Neeman, F Mourad European Journal of Haematology 67 (1), 30-34, 2001 | 99 | 2001 |
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States M Sheikh-Taha, M Asmar BMC geriatrics 21, 1-6, 2021 | 85 | 2021 |
Efficacy and tolerability of peginterferon alpha‐2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection A Inati, A Taher, S Ghorra, S Koussa, M Taha, E Aoun, AI Sharara British journal of haematology 130 (4), 644-646, 2005 | 80 | 2005 |
Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA M Sheikh-Taha, H Dimassi BMC Cardiovascular Disorders 17, 1-6, 2017 | 58 | 2017 |
Treatment of apixaban-and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate M Sheikh-Taha Internal and Emergency Medicine 14, 265-269, 2019 | 47 | 2019 |
Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis M Sheikh-Taha, LC Corman Multiple Sclerosis Journal 23 (6), 872-874, 2017 | 44 | 2017 |
Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease A Inati, KM Musallam, JC Wood, M Sheikh‐Taha, L Daou, AT Taher European journal of haematology 83 (6), 565-571, 2009 | 44 | 2009 |
Safety and effectiveness of 100 mg/kg/day deferiprone in patients with thalassemia major: a two-year study A Taher, M Sheikh-Taha, A Sharara, A Inati, S Koussa, G Ellis, AP Dhillon, ... Acta haematologica 114 (3), 146-149, 2005 | 40 | 2005 |
Use of acid suppressive therapy in hospitalized non-critically ill patients M Sheikh-Taha, S Alaeddine, J Nassif World Journal of Gastrointestinal Pharmacology and Therapeutics 3 (6), 93, 2012 | 35 | 2012 |
Effect of age and sex on warfarin dosing G Khoury, M Sheikh-Taha Clinical pharmacology: advances and applications, 103-106, 2014 | 33 | 2014 |
Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study WH Ramadan, GM El Khoury, ME Deeb, M Sheikh-Taha Neuropsychiatric Disease and Treatment, 2299-2305, 2016 | 25 | 2016 |
Idarucizumab for reversal of dabigatran: single-center real-world experience M Sheikh-Taha American Journal of Cardiovascular Drugs 19, 59-64, 2019 | 22 | 2019 |
Possible montelukast-induced angioedema R Sabbagh, M Sheikh-Taha American Journal of Health-System Pharmacy 66 (19), 1705-1706, 2009 | 15 | 2009 |
Reversal of apixaban and rivaroxaban using activated prothrombin complex concentrates in patients with major bleeding M Sheikh-Taha, RM Crawley American Journal of Cardiovascular Drugs 20, 295-299, 2020 | 12 | 2020 |
Evaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals M Sheikh-Taha, Z Hijazi Springerplus 3, 1-6, 2014 | 12 | 2014 |
Oral aphthous ulcers associated with orlistat M Sheikh-Taha, S Ghosn, A Zeitoun American Journal of Health-System Pharmacy 69 (17), 1462-1464, 2012 | 11 | 2012 |
Hydroxyurea use in lebanese patients with β-thalassemia intermedia A Taher, M Sheikh-Taha Journal of Pediatric Hematology/Oncology 28 (2), 107, 2006 | 11 | 2006 |
Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA M Sheikh-Taha, H Dimassi BMC geriatrics 18, 1-6, 2018 | 9 | 2018 |
Use of deep vein thrombosis prophylaxis in hospitalized cancer patients Z Awar, M Sheikh-Taha Blood coagulation & fibrinolysis 20 (7), 571-574, 2009 | 8 | 2009 |